BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 18370214)

  • 1. IL-2 plasmid electroporation: from preclinical studies to phase I clinical trial.
    Horton HM; Lalor PA; Rolland AP
    Methods Mol Biol; 2008; 423():361-72. PubMed ID: 18370214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
    O'Malley BW; Li D; McQuone SJ; Ralston R
    Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective tumor therapy with plasmid-encoded cytokines combined with in vivo electroporation.
    Lohr F; Lo DY; Zaharoff DA; Hu K; Zhang X; Li Y; Zhao Y; Dewhirst MW; Yuan F; Li CY
    Cancer Res; 2001 Apr; 61(8):3281-4. PubMed ID: 11309280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic IL-12 gene therapy for treating malignancy via intramuscular electroporation.
    Zhu S; Li S
    Methods Mol Biol; 2008; 423():327-37. PubMed ID: 18370211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of DNA into tumors.
    Li S
    Methods Mol Biol; 2008; 423():311-8. PubMed ID: 18370209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of SCCVII tumors with systemic chemotherapy and Interleukin-12 gene therapy combination.
    Torrero M; Li S
    Methods Mol Biol; 2008; 423():339-49. PubMed ID: 18370212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of DNA into bladder via electroporation.
    Yoshida M; Iwashita H; Otani M; Masunaga K; Inadome A
    Methods Mol Biol; 2008; 423():249-57. PubMed ID: 18370204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor IX gene therapy for hemophilia.
    Fewell JG
    Methods Mol Biol; 2008; 423():375-82. PubMed ID: 18370215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-2 plasmid therapy of murine ovarian carcinoma inhibits the growth of tumor ascites and alters its cytokine profile.
    Horton HM; Dorigo O; Hernandez P; Anderson D; Berek JS; Parker SE
    J Immunol; 1999 Dec; 163(12):6378-85. PubMed ID: 10586027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete regression of established subcutaneous B16 murine melanoma tumors after delivery of an HIV-1 Vpr-expressing plasmid by in vivo electroporation.
    McCray AN; Ugen KE; Muthumani K; Kim JJ; Weiner DB; Heller R
    Mol Ther; 2006 Nov; 14(5):647-55. PubMed ID: 16950655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KGF-1 for wound healing in animal models.
    Marti GP; Mohebi P; Liu L; Wang J; Miyashita T; Harmon JW
    Methods Mol Biol; 2008; 423():383-91. PubMed ID: 18370216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocyte growth factor gene therapy for hypertension.
    Komamura K; Miyazaki J; Imai E; Matsumoto K; Nakamura T; Hori M
    Methods Mol Biol; 2008; 423():393-404. PubMed ID: 18370217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technology evaluation: gene therapy (IL-2), Valentis Inc.
    Morse MA
    Curr Opin Mol Ther; 2000 Aug; 2(4):448-52. PubMed ID: 11249776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene delivery to dystrophic muscle.
    Wells KE; McMahon J; Foster H; Ferrer A; Wells DJ
    Methods Mol Biol; 2008; 423():421-31. PubMed ID: 18370219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery of DNA into muscle for treating systemic diseases: advantages and challenges.
    Trollet C; Scherman D; Bigey P
    Methods Mol Biol; 2008; 423():199-214. PubMed ID: 18370200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of DNA into skin via electroporation.
    Medi BM; Singh J
    Methods Mol Biol; 2008; 423():225-32. PubMed ID: 18370202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technology evaluation: interleukin-2 gene therapy for the treatment of renal cell carcinoma.
    Figlin RA; Parker SE; Horton HM
    Curr Opin Mol Ther; 1999 Apr; 1(2):271-8. PubMed ID: 11715951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy of spontaneous canine melanoma and feline fibrosarcoma by intratumoral administration of histoincompatible cells expressing human interleukin-2.
    Quintin-Colonna F; Devauchelle P; Fradelizi D; Mourot B; Faure T; Kourilsky P; Roth C; Mehtali M
    Gene Ther; 1996 Dec; 3(12):1104-12. PubMed ID: 8986437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel jet-injection technology for nonviral intratumoral gene transfer in patients with melanoma and breast cancer.
    Walther W; Siegel R; Kobelt D; Knösel T; Dietel M; Bembenek A; Aumann J; Schleef M; Baier R; Stein U; Schlag PM
    Clin Cancer Res; 2008 Nov; 14(22):7545-53. PubMed ID: 19010873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of DNA into skeletal muscle in large animals.
    Brown PA; Khan AS; Draghia-Akli R
    Methods Mol Biol; 2008; 423():215-24. PubMed ID: 18370201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.